Infliximab‐induced autoimmune hepatitis requiring liver transplantation

Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and trial of prednisone. We present a rare case of infliximab‐i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Frederick, Al Ibrahim, Bashaar, Walsh, Joanna, Qumosani, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878066/
https://www.ncbi.nlm.nih.gov/pubmed/31788265
http://dx.doi.org/10.1002/ccr3.2456
_version_ 1783473462188179456
author Wong, Frederick
Al Ibrahim, Bashaar
Walsh, Joanna
Qumosani, Karim
author_facet Wong, Frederick
Al Ibrahim, Bashaar
Walsh, Joanna
Qumosani, Karim
author_sort Wong, Frederick
collection PubMed
description Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and trial of prednisone. We present a rare case of infliximab‐induced autoimmune hepatitis leading to liver failure requiring transplantation.
format Online
Article
Text
id pubmed-6878066
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68780662019-11-29 Infliximab‐induced autoimmune hepatitis requiring liver transplantation Wong, Frederick Al Ibrahim, Bashaar Walsh, Joanna Qumosani, Karim Clin Case Rep Case Reports Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and trial of prednisone. We present a rare case of infliximab‐induced autoimmune hepatitis leading to liver failure requiring transplantation. John Wiley and Sons Inc. 2019-09-27 /pmc/articles/PMC6878066/ /pubmed/31788265 http://dx.doi.org/10.1002/ccr3.2456 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Wong, Frederick
Al Ibrahim, Bashaar
Walsh, Joanna
Qumosani, Karim
Infliximab‐induced autoimmune hepatitis requiring liver transplantation
title Infliximab‐induced autoimmune hepatitis requiring liver transplantation
title_full Infliximab‐induced autoimmune hepatitis requiring liver transplantation
title_fullStr Infliximab‐induced autoimmune hepatitis requiring liver transplantation
title_full_unstemmed Infliximab‐induced autoimmune hepatitis requiring liver transplantation
title_short Infliximab‐induced autoimmune hepatitis requiring liver transplantation
title_sort infliximab‐induced autoimmune hepatitis requiring liver transplantation
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878066/
https://www.ncbi.nlm.nih.gov/pubmed/31788265
http://dx.doi.org/10.1002/ccr3.2456
work_keys_str_mv AT wongfrederick infliximabinducedautoimmunehepatitisrequiringlivertransplantation
AT alibrahimbashaar infliximabinducedautoimmunehepatitisrequiringlivertransplantation
AT walshjoanna infliximabinducedautoimmunehepatitisrequiringlivertransplantation
AT qumosanikarim infliximabinducedautoimmunehepatitisrequiringlivertransplantation

Ejemplares similares